Dana-Farber Cancer Institute
Ann H. Partridge, MD, MPH

Ann H. Partridge, MD, MPH

Medical Oncology
MAKE AN APPOINTMENT

Contact Information

Office Phone Number

617-632-3800

Fax

617-632-1930

Appointments

617-632-2175

On This Page

Biography

Ann H. Partridge, MD, MPH

Dr. Ann Partridge is interim chair of the Department of Medical Oncology at Dana-Farber Cancer Institute, where she also serves as director of the Adult Survivorship Program and co-founder and director of the Program for Young Adults with Breast Cancer. A professor at Harvard Medical School, Dr. Partridge holds the Eric P. Winer, MD, Chair in Breast Cancer Research at Dana-Farber. She conducts clinical research focused on improving cancer care and outcomes with a particular focus on young adults with breast cancer. Dr. Partridge serves on the Board of Directors of the American Society of Clinical Oncology (ASCO); co-chairs the National Cancer Institute (NCI) Alliance for Clinical Trials in Oncology Breast Committee; and serves on the NCI Breast Cancer Steering Committee. She is also a Chief Scientific Advisor for Susan G. Komen and an American Cancer Society Clinical Research Professor. Her research has been supported by the NCI, Breast Cancer Research Foundation (BCRF), Conquer Cancer, the American Cancer Society, and Susan G. Komen. Dr. Partridge received a Champions of Change award from the U.S. White House, the American Association for Clinical Research (AACR) Outstanding Investigator Award for Breast Cancer, the ASCO Ellen L. Stovall Award for Advancement of Cancer Survivorship Care, and the 2024 ESMO Award from the European Society of Medical Oncology for her commitment and groundbreaking work advancing the field of breast cancer research. Dr. Partridge received her bachelor’s degree from Georgetown University before earning her medical degree from Cornell University Medical College. She completed her residency at the University of Pennsylvania School of Medicine and earned her Master of Public Health degree from the Harvard School of Public Health.

 

 

Researcher

Physician

Interim Chair of Medical Oncology
Founder and Director, Program for Young Adults with Breast Cancer
Director, Adult Survivorship Program
Eric P. Winer, MD, Chair in Breast Cancer Research at Dana-Farber
Senior Physician
Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

Breast cancer in young adults

Diseases Treated

Board Certification

  • Hematology, 2001
  • Internal Medicine, 1998
  • Medical Oncology, 2001

Fellowship

  • Dana-Farber/Partners CancerCare, Hematology/Oncology

Residency

  • University of Pennsylvania School of Medicine, Internal Medicine

Medical School

  • Weill Medical College of Cornell University

Recent Awards

  • Champions of Change Award, U.S. White House
  • Outstanding Investigator Award for Breast Cancer, AACR
  • Ellen L. Stovall Award for Advancement of Cancer Survivorship Care, ASCO
  • ESMO Award, European Society of Medical Oncology 2024

Research

    View Dr. Partridge’s Research

    Clinical and Epidemiologic Research in Breast Cancer

    Although the median age at breast cancer diagnosis is approximately 61, more than 14,000 women 40 years of age or younger are diagnosed with breast cancer each year in the United States alone.  Because women in this younger age group represent a minority of the women diagnosed with breast cancer, far less is known about breast cancer in younger women than older women.  My research focuses on the issues facing young women with breast cancer.  Several ongoing projects include assessment of fertility and feasibility and safety of pregnancy in young women breast cancer patients, optimizing delivery of supportive care to this vulnerable population, and the unique biology of young onset disease.

    Research Departments

    Support my research

    Research Website

    https://youngandstrong.dana-farber.org/research-studies.html

    Publications

      View Dr. Partridge's Publications

      • INteractive survivorship program to improve health care REsources [INSPIRE]: A study protocol testing a digital intervention with stepped care telehealth to improve outcomes for adolescent and young adult survivors. Contemp Clin Trials. 2024 Nov 17; 148:107745. View in: Pubmed

      • Financial Difficulty Over Time in Young Adults With Breast Cancer. JAMA Netw Open. 2024 Nov 04; 7(11):e2446091. View in: Pubmed

      • Patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2024 Oct 21. View in: Pubmed

      • Breastfeeding experiences among young breast cancer survivors: A survey study. Cancer. 2024 Sep 29. View in: Pubmed

      • Contraception use and changes in young women with newly diagnosed breast cancer. Fertil Steril. 2024 Sep 19. View in: Pubmed

      • Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology. ESMO Open. 2024 Oct; 9(10):103714. View in: Pubmed

      • Reply to Z Wen et al and S Liu et al. J Clin Oncol. 2024 Dec; 42(34):4116-4117. View in: Pubmed

      • Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort study. Br J Surg. 2024 08 30; 111(9). View in: Pubmed

      • Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502. NPJ Breast Cancer. 2024 Aug 21; 10(1):75. View in: Pubmed

      • Effects of Adjuvant Endocrine Therapy-Specific Perceptions on Response to a Behavioral Intervention for Adjuvant Endocrine Therapy Adherence in Patients With Breast Cancer. JCO Oncol Pract. 2024 Aug 13; OP2400316. View in: Pubmed

      • Mediators of a Mindfulness-Based Intervention for Younger Breast Cancer Survivors: Effects on Depressive Symptoms. Psychosom Med. 2024 Oct 01; 86(8):700-709. View in: Pubmed

      • A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years later. Ann Oncol. 2024 Nov; 35(11):1048-1060. View in: Pubmed

      • Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy. NPJ Breast Cancer. 2024 Aug 01; 10(1):67. View in: Pubmed

      • ASO Visual Abstract: Validation of the AJCC Eighth-Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01). Ann Surg Oncol. 2024 Jul 16. View in: Pubmed

      • Association of cancer treatment with excess heart age among five-year young breast cancer survivors. J Cancer Surviv. 2024 Jul 15. View in: Pubmed

      • Hormone receptor-positive early breast cancer in young women: A comprehensive review. Cancer Treat Rev. 2024 Sep; 129:102804. View in: Pubmed

      • Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer. Breast. 2024 Oct; 77:103765. View in: Pubmed

      • Helping ourselves, helping others: the Young Women's Breast Cancer Study (YWS) - a multisite prospective cohort study to advance the understanding of breast cancer diagnosed in women aged 40 years and younger. BMJ Open. 2024 Jul 01; 14(6):e081157. View in: Pubmed

      • Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. J Clin Oncol. 2024 Nov; 42(31):3652-3665. View in: Pubmed

      • OptimICE-RD: sacituzumab govitecan + pembrolizumab vs pembrolizumab (± capecitabine) for residual triple-negative breast cancer. Future Oncol. 2024; 20(31):2343-2355. View in: Pubmed

      • Moderators of Intervention Efficacy in the Pathways to Wellness Trial of Survivorship Education and Mindfulness Meditation for Younger Breast Cancer Survivors. JCO Oncol Pract. 2024 Oct; 20(10):1410-1419. View in: Pubmed

      • Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers. Ann Oncol. 2024 Sep; 35(9):792-804. View in: Pubmed

      • Second primary non-breast cancers in young breast cancer survivors. Breast Cancer Res Treat. 2024 Oct; 207(3):587-597. View in: Pubmed

      • Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601). J Geriatr Oncol. 2024 07; 15(6):101813. View in: Pubmed

      • Association of N-terminal pro-brain natriuretic peptide with survival among US cancer survivors. J Natl Cancer Inst. 2024 Jun 07; 116(6):938-947. View in: Pubmed

      • Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01). Ann Surg Oncol. 2024 Sep; 31(9):5880-5887. View in: Pubmed

      • Second Primary Breast Cancer in Young Breast Cancer Survivors. JAMA Oncol. 2024 Jun 01; 10(6):718-725. View in: Pubmed

      • Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy. J Clin Oncol. 2024 Aug 10; 42(23):2822-2832. View in: Pubmed

      • 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7). Breast. 2024 Aug; 76:103756. View in: Pubmed

      • Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial. JAMA. 2024 05 28; 331(20):1714-1721. View in: Pubmed

      • Psychosocial and supportive care concerns of young women living with advanced breast cancer: baseline findings from a prospective virtual support intervention study. Support Care Cancer. 2024 May 10; 32(6):336. View in: Pubmed

      • Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer. NPJ Breast Cancer. 2024 Apr 16; 10(1):28. View in: Pubmed

      • Correction to: Cancer survivorship programs at the Dana-Farber Cancer Institute. J Cancer Surviv. 2024 Apr 12. View in: Pubmed

      • Breast Cancer and Pregnancy in Young BRCA Carriers-Reply. JAMA. 2024 04 09; 331(14):1234. View in: Pubmed

      • PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer. J Clin Oncol. 2024 Jun 10; 42(17):2050-2060. View in: Pubmed

      • Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nat Commun. 2024 Mar 19; 15(1):2446. View in: Pubmed

      • Managing menopause after cancer. Lancet. 2024 03 09; 403(10430):984-996. View in: Pubmed

      • Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 01; 10(3):362-371. View in: Pubmed

      • Approaching cancer during pregnancy. Nat Rev Cancer. 2024 Mar; 24(3):159-160. View in: Pubmed

      • 2023 Year in review: Early breast cancer. Breast. 2024 Apr; 74:103700. View in: Pubmed

      • Prevalence and impact of fertility concerns in young women with breast cancer. Sci Rep. 2024 02 22; 14(1):4418. View in: Pubmed

      • Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2- Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7. Clin Cancer Res. 2024 02 16; 30(4):793-802. View in: Pubmed

      • Cancer survivorship programs at the Dana-Farber Cancer Institute. J Cancer Surviv. 2024 02; 18(1):34-41. View in: Pubmed

      • Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial. Breast Cancer Res Treat. 2024 Apr; 204(3):547-559. View in: Pubmed

      • Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study. JAMA. 2024 01 02; 331(1):49-59. View in: Pubmed

      • Fertility concerns and treatment decision-making among national sample of young women with breast cancer. Cancer Med. 2024 Jan; 13(1):e6838. View in: Pubmed

      • Work Productivity Among Younger Breast Cancer Survivors: The Impact of Behavioral Interventions for Depression. Value Health. 2024 03; 27(3):322-329. View in: Pubmed

      • Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. Proc Natl Acad Sci U S A. 2023 Dec 05; 120(49):e2316763120. View in: Pubmed

      • Taking their wellbeing into their own hands: Self-educated and peer-recommended techniques used by women with breast cancer to improve sexual functioning during treatment and in survivorship. PLoS One. 2023; 18(11):e0293298. View in: Pubmed

      • When Cancer Centers Snooze, Patients Lose: It is Time to Make Insomnia a Priority for Survivors. JCO Oncol Pract. 2024 Feb; 20(2):169-172. View in: Pubmed

      • Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017. Cancer. 2024 03 01; 130(5):750-769. View in: Pubmed

      • Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors. Cancer. 2024 02 15; 130(4):517-529. View in: Pubmed

      • Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis. ESMO Open. 2023 Dec; 8(6):102031. View in: Pubmed

      • Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival. JAMA Netw Open. 2023 10 02; 6(10):e2339584. View in: Pubmed

      • Family Caregiver Experiences in the Inpatient and Outpatient Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Settings: A Qualitative Study. Transplant Cell Ther. 2024 Jun; 30(6):610.e1-610.e16. View in: Pubmed

      • Endometrial Cancer Risk Among Germline BRCA1/2 Pathogenic Variant Carriers: Review of Our Current Understanding and Next Steps. JCO Precis Oncol. 2023 09; 7:e2300290. View in: Pubmed

      • Satisfaction with Care and Attention to Age-Specific Concerns by Race and Ethnicity in a National Sample of Young Women with Breast Cancer. J Adolesc Young Adult Oncol. 2024 Feb; 13(1):105-111. View in: Pubmed

      • Survivorship Navigation for Young Women With Early-Stage Breast Cancer. Clin Breast Cancer. 2023 10; 23(7):746-751.e1. View in: Pubmed

      • Clonal Hematopoiesis in Young Women Treated for Breast Cancer. Clin Cancer Res. 2023 07 05; 29(13):2551-2558. View in: Pubmed

      • Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies. Oncologist. 2023 07 05; 28(7):565-574. View in: Pubmed

      • Fertility and Sexual Health in Young Women with Early-Stage Breast Cancer. Surg Oncol Clin N Am. 2023 10; 32(4):747-759. View in: Pubmed

      • Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO Precis Oncol. 2023 06; 7:e2300076. View in: Pubmed

      • Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial. J Am Coll Surg. 2023 08 01; 237(2):247-256. View in: Pubmed

      • Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. N Engl J Med. 2023 May 04; 388(18):1645-1656. View in: Pubmed

      • Patient-Centered Care in the Management of Cancer During Pregnancy. Am Soc Clin Oncol Educ Book. 2023 May; 43:e100037. View in: Pubmed

      • Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors. NPJ Breast Cancer. 2023 Apr 25; 9(1):31. View in: Pubmed

      • Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong Study. Cancer. 2023 07 15; 129(14):2135-2143. View in: Pubmed

      • Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). J Clin Oncol. 2023 06 10; 41(17):3184-3193. View in: Pubmed

      • Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts. Cancer. 2023 06 15; 129(12):1836-1845. View in: Pubmed

      • The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT-01). Cancer. 2023 05 01; 129(9):1351-1360. View in: Pubmed

      • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. Lancet Oncol. 2023 03; 24(3):273-285. View in: Pubmed

      • Germline TP53 pathogenic variants and breast cancer: A narrative review. Cancer Treat Rev. 2023 Mar; 114:102522. View in: Pubmed

      • Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ. Radiology. 2023 04; 307(1):e221210. View in: Pubmed

      • Improving biobehavioral health in younger breast cancer survivors: Pathways to Wellness trial secondary outcomes. J Natl Cancer Inst. 2023 01 10; 115(1):83-92. View in: Pubmed

      • Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. J Natl Compr Canc Netw. 2023 01; 21(1):33-41.e16. View in: Pubmed

      • Primary care providers' comfort in caring for cancer survivors: Implications for risk-stratified care. Pediatr Blood Cancer. 2023 04; 70(4):e30174. View in: Pubmed

      • Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Adv. 2022 12 27; 6(24):6151-6161. View in: Pubmed

      • Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers. Clin Breast Cancer. 2023 04; 23(3):317-323. View in: Pubmed

      • Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholders. Am J Cancer Res. 2022; 12(12):5599-5612. View in: Pubmed

      • Local/Regional Recurrence Rates After Breast-Conserving Therapy in Patients Enrolled in Legacy Trials of the Alliance for Clinical Trials in Oncology (AFT-01). Ann Surg. 2023 05 01; 277(5):841-845. View in: Pubmed

      • ASO Visual Abstract: Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ. Ann Surg Oncol. 2022 Dec; 29(13):8058-8059. View in: Pubmed

      • Increased Clinical Pain Locations and Pain Sensitivity in Women After Breast Cancer Surgery: Influence of Aromatase Inhibitor Therapy. Clin J Pain. 2022 12 01; 38(12):721-729. View in: Pubmed

      • Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT). NPJ Breast Cancer. 2022 Nov 30; 8(1):127. View in: Pubmed

      • Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer. Breast Cancer Res Treat. 2023 Feb; 197(3):547-558. View in: Pubmed

      • Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01). J Natl Cancer Inst. 2022 10 06; 114(10):1371-1379. View in: Pubmed

      • Early postoperative psychological distress as a mediator of subsequent persistent postsurgical pain outcomes among younger breast cancer patients. Breast Cancer Res Treat. 2022 Nov; 196(2):363-370. View in: Pubmed

      • Contraceptive Use in Premenopausal Women With Early Breast Cancer. JAMA Netw Open. 2022 09 01; 5(9):e2233137. View in: Pubmed

      • Coping strategies and anxiety in young breast cancer survivors. Support Care Cancer. 2022 Nov; 30(11):9109-9116. View in: Pubmed

      • Clinicopathologic Features, Treatment Patterns, and Disease Outcomes in a Modern, Prospective Cohort of Young Women Diagnosed with Ductal Carcinoma In Situ. Ann Surg Oncol. 2022 Dec; 29(13):8048-8057. View in: Pubmed

      • ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol. 2022 11; 33(11):1119-1133. View in: Pubmed

      • Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy. J Natl Cancer Inst. 2022 08 08; 114(8):1117-1126. View in: Pubmed

      • ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann Oncol. 2022 11; 33(11):1097-1118. View in: Pubmed

      • A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial. Cancer. 2022 10 01; 128(19):3541-3551. View in: Pubmed

      • Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors. Cancer. 2022 09 01; 128(17):3158-3169. View in: Pubmed

      • The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy. Breast Cancer Res Treat. 2022 Aug; 194(3):663-672. View in: Pubmed

      • Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. Breast. 2022 Oct; 65:32-40. View in: Pubmed

      • Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis. Breast Cancer Res Treat. 2022 Aug; 194(3):597-606. View in: Pubmed

      • Overcoming Obstacles in Transitions of Cancer Survivor Care. J Natl Cancer Inst. 2022 06 13; 114(6):785-786. View in: Pubmed

      • Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland. J Cancer Surviv. 2023 12; 17(6):1847-1858. View in: Pubmed

      • Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer. J Clin Oncol. 2022 08 01; 40(22):2408-2419. View in: Pubmed

      • Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer. Clin Cancer Res. 2022 06 01; 28(11):2339-2348. View in: Pubmed

      • Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials. NPJ Breast Cancer. 2022 May 24; 8(1):68. View in: Pubmed

      • Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials. Breast. 2022 Aug; 64:56-62. View in: Pubmed

      • A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer. NPJ Breast Cancer. 2022 May 10; 8(1):63. View in: Pubmed

      • Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy. J Clin Oncol. 2022 09 20; 40(27):3190-3204. View in: Pubmed

      • Treatment of Breast Cancer in Young Adults. Am Soc Clin Oncol Educ Book. 2022 Apr; 42:1-12. View in: Pubmed

      • Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis. J Clin Oncol. 2022 07 01; 40(19):2148-2162. View in: Pubmed

      • "Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ. Cancer. 2022 04 15; 128(8):1676-1683. View in: Pubmed

      • Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer. JAMA Netw Open. 2022 Feb 01; 5(2):e220254. View in: Pubmed

      • Psychosocial issues and quality of life of parenting partners of young women with breast cancer. Support Care Cancer. 2022 May; 30(5):4265-4274. View in: Pubmed

      • Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care. J Clin Oncol. 2022 04 01; 40(10):1111-1123. View in: Pubmed

      • Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033): A Phase II Randomized Trial of Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab in Women With Stage I HER2-Positive Breast Cancer. Int J Radiat Oncol Biol Phys. 2022 05 01; 113(1):117-124. View in: Pubmed

      • The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity (Silver Spring). 2022 01; 30(1):28-38. View in: Pubmed

      • The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis. Breast. 2022 Feb; 61:77-83. View in: Pubmed

      • Correction to: Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis. Cancer Causes Control. 2021 Dec; 32(12):1407-1409. View in: Pubmed

      • ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Ann Surg Oncol. 2021 12; 28(Suppl 3):436-437. View in: Pubmed

      • Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation. J Natl Cancer Inst. 2021 11 29; 113(12):1770-1778. View in: Pubmed

      • Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer. ESMO Open. 2021 12; 6(6):100300. View in: Pubmed

      • Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer. Br J Cancer. 2022 02; 126(2):302-309. View in: Pubmed

      • Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. Future Oncol. 2021 Dec; 17(34):4665-4676. View in: Pubmed

      • Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions. JCO Oncol Pract. 2022 03; 18(3):211-216. View in: Pubmed

      • Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022 Jan 15; 128(2):335-343. View in: Pubmed

      • Association of Local Therapy With Quality-of-Life Outcomes in Young Women With Breast Cancer. JAMA Surg. 2021 10 01; 156(10):e213758. View in: Pubmed

      • Cyclophosphamide-Free Adjuvant Chemotherapy for the Potential Prevention of Premature Ovarian Insufficiency and Infertility in Young Women With Breast Cancer. J Natl Cancer Inst. 2021 10 01; 113(10):1274-1276. View in: Pubmed

      • The effects of a clinic-based weight loss program on health-related quality of life and weight maintenance in cancer survivors: A randomized controlled trial. Psychooncology. 2022 02; 31(2):326-333. View in: Pubmed

      • Reply to M. Tanaka et al. J Clin Oncol. 2021 11 10; 39(32):3648-3649. View in: Pubmed

      • Cancer Survivorship in Latin America: Current Status and Opportunities. JCO Glob Oncol. 2021 09; 7:1472-1479. View in: Pubmed

      • Targeting Depressive Symptoms in Younger Breast Cancer Survivors: The Pathways to Wellness Randomized Controlled Trial of Mindfulness Meditation and Survivorship Education. J Clin Oncol. 2021 11 01; 39(31):3473-3484. View in: Pubmed

      • Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis. Cancer Causes Control. 2021 Dec; 32(12):1395-1405. View in: Pubmed

      • Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy. Breast. 2021 Oct; 59:327-338. View in: Pubmed

      • Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea. J Natl Cancer Inst. 2021 08 02; 113(8):1105-1108. View in: Pubmed

      • Young, Empowered and Strong: A Web-Based Education and Supportive Care Intervention for Young Women With Breast Cancer Across the Care Continuum. JCO Clin Cancer Inform. 2021 08; 5:933-943. View in: Pubmed

      • Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer. NPJ Breast Cancer. 2021 Jul 27; 7(1):99. View in: Pubmed

      • Pregnancy After Breast Cancer: A Systematic Review and Meta-Analysis. J Clin Oncol. 2021 10 10; 39(29):3293-3305. View in: Pubmed

      • The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival. Cancer. 2021 10 15; 127(20):3872-3880. View in: Pubmed

      • Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial). Breast Cancer Res Treat. 2021 Aug; 189(1):103-110. View in: Pubmed

      • Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID-19. Oncologist. 2021 08; 26(8):685-693. View in: Pubmed

      • Optimizing Decision Making for Ductal Carcinoma in Situ: Facts Over Fear. J Natl Cancer Inst. 2021 05 04; 113(5):511-512. View in: Pubmed

      • Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer. 2021 08 15; 127(16):2888-2894. View in: Pubmed

      • Arm Morbidity After Local Therapy for Young Breast Cancer Patients. Ann Surg Oncol. 2021 Oct; 28(11):6071-6082. View in: Pubmed

      • Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. Lancet Oncol. 2021 07; 22(7):e303-e313. View in: Pubmed

      • Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance). JNCI Cancer Spectr. 2021 06; 5(3). View in: Pubmed

      • Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy. J Natl Cancer Inst. 2021 04 06; 113(4):443-452. View in: Pubmed

      • Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance). Ann Surg Oncol. 2021 Oct; 28(11):5960-5971. View in: Pubmed

      • Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer. Cancer Chemother Pharmacol. 2021 05; 87(5):673-679. View in: Pubmed

      • Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants. NPJ Breast Cancer. 2021 Feb 12; 7(1):16. View in: Pubmed

      • Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health Questionnaire. JNCI Cancer Spectr. 2021 06; 5(3). View in: Pubmed

      • A new look at old problems: Ovarian function suppression in the real world. Cancer. 2021 04 15; 127(8):1174-1176. View in: Pubmed

      • Comparison of Equations To Estimate Glomerular Filtration Rate and Their Impact on Frequency of Cisplatin-associated Acute Kidney Injury. Kidney360. 2021 02 25; 2(2):205-214. View in: Pubmed

      • Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study. Ann Surg. 2022 07 01; 276(1):173-179. View in: Pubmed

      • Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer. Cancer. 2021 04 01; 127(7):1021-1028. View in: Pubmed

      • Tumor phenotype and concordance in synchronous bilateral breast cancer in young women. Breast Cancer Res Treat. 2021 Apr; 186(3):815-821. View in: Pubmed

      • Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer. JACC CardioOncol. 2020 Nov; 2(4):553-563. View in: Pubmed

      • Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat. 2021 Feb; 186(1):157-165. View in: Pubmed

      • Body weight and return to work among survivors of early-stage breast cancer. ESMO Open. 2020 11; 5(6):e000908. View in: Pubmed

      • Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors. JAMA Surg. 2020 11 01; 155(11):1035-1042. View in: Pubmed

      • Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial. JAMA. 2020 10 13; 324(14):1406-1418. View in: Pubmed

      • Prospective evaluation of the impact of stress, anxiety, and depression on household income among young women with early breast cancer from the Young and Strong trial. BMC Public Health. 2020 Oct 06; 20(1):1514. View in: Pubmed

      • Partners of young breast cancer survivors: a cross-sectional evaluation of psychosocial concerns, coping, and mental health. J Psychosoc Oncol. 2020 Nov-Dec; 38(6):670-686. View in: Pubmed

      • Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. 2020 10 01; 6(10):1598-1605. View in: Pubmed

      • Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer. Eur Heart J Qual Care Clin Outcomes. 2020 10 01; 6(4):315-322. View in: Pubmed

      • The utility of magnetic resonance imaging in early-stage breast cancer survivors-An institutional experience and literature review. Breast J. 2020 09; 26(9):1673-1679. View in: Pubmed

      • Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations. J Clin Oncol. 2020 09 10; 38(26):3012-3023. View in: Pubmed

      • Posttraumatic stress in breast cancer survivors diagnosed at a young age. Psychooncology. 2020 08; 29(8):1312-1320. View in: Pubmed

      • Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab. Clin Cancer Res. 2020 09 15; 26(18):4911-4920. View in: Pubmed

      • Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk. J Clin Oncol. 2020 08 20; 38(24):2762-2772. View in: Pubmed

      • Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial. Breast. 2020 Oct; 53:1-7. View in: Pubmed

      • Hodgkin Lymphoma Survivor Wellness: Development of a Web-Based Intervention. Clin J Oncol Nurs. 2020 06 01; 24(3):284-289. View in: Pubmed

      • Prediction of Breast Cancer Treatment-Induced Fatigue by Machine Learning Using Genome-Wide Association Data. JNCI Cancer Spectr. 2020 Oct; 4(5):pkaa039. View in: Pubmed

      • Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review. J Natl Cancer Inst. 2020 05 01; 112(5):443-465. View in: Pubmed

      • Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study. Breast. 2020 Aug; 52:23-32. View in: Pubmed

      • ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4). Ann Oncol. 2020 06; 31(6):674-696. View in: Pubmed

      • Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clin Cancer Res. 2020 06 01; 26(11):2556-2564. View in: Pubmed

      • Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients. PLoS One. 2020; 15(3):e0230529. View in: Pubmed

      • Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019 Nov; 30(11):1784-1795. View in: Pubmed

      • Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. J Clin Oncol. 2020 03 01; 38(7):725-733. View in: Pubmed

      • Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). Ann Oncol. 2012 Dec; 23(12):3075-3081. View in: Pubmed

      • Clinical Benefit in the Treatment of Patients with Early Breast Cancer. Breast. 2019 Nov; 48 Suppl 1:S115-S118. View in: Pubmed

      • Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019 11 01; 30(11):1784-1795. View in: Pubmed

      • Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. Oncologist. 2020 04; 25(4):310-318. View in: Pubmed

      • Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial. Oncologist. 2019 Oct 14. View in: Pubmed

      • Aggressive Subsets of Metastatic Triple Negative Breast Cancer. Clin Breast Cancer. 2020 02; 20(1):e20-e26. View in: Pubmed

      • Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer. Fertil Steril. 2019 10; 112(4):731-739.e1. View in: Pubmed

      • Impact of Timing on Measurement of Decision Quality and Shared Decision Making: Longitudinal Cohort Study of Breast Cancer Patients. Med Decis Making. 2019 08; 39(6):642-650. View in: Pubmed

      • Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial. J Clin Oncol. 2019 09 10; 37(26):2338-2348. View in: Pubmed

      • Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer. Breast J. 2019 11; 25(6):1104-1110. View in: Pubmed

      • Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers. Breast. 2019 Oct; 47:85-92. View in: Pubmed

      • Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2019 08 20; 37(24):2120-2130. View in: Pubmed

      • Employment trends in young women following a breast cancer diagnosis. Breast Cancer Res Treat. 2019 Aug; 177(1):207-214. View in: Pubmed

      • Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients. PLoS One. 2019; 14(5):e0216997. View in: Pubmed

      • Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer. Cancer. 2019 09 15; 125(18):3266-3274. View in: Pubmed

      • Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). Breast Cancer Res Treat. 2019 Jul; 176(2):303-310. View in: Pubmed

      • Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ. Mod Pathol. 2019 09; 32(9):1257-1262. View in: Pubmed

      • Cancer Treatment-Related Infertility: A Critical Review of the Evidence. JNCI Cancer Spectr. 2019 Mar; 3(1):pkz008. View in: Pubmed

      • Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast Cancer. J Adolesc Young Adult Oncol. 2019 08; 8(4):463-468. View in: Pubmed

      • Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. J Clin Oncol. 2019 08 01; 37(22):1868-1875. View in: Pubmed

      • Developing a Novel Model to Improve Research and care for Cancer Survivors: a Feasibility Study. J Cancer Educ. 2019 04; 34(2):229-233. View in: Pubmed

      • Identifying distinct trajectories of change in young breast cancer survivors' sexual functioning. Psychooncology. 2019 05; 28(5):1033-1040. View in: Pubmed

      • Fatigue and physical activity in cancer survivors: A cross-sectional population-based study. Cancer Med. 2019 05; 8(5):2535-2544. View in: Pubmed

      • Amenorrhea after lung cancer treatment. Menopause. 2019 03; 26(3):306-310. View in: Pubmed

      • Reproductive Health Issues for Young Women with Breast Cancer: Emerging Strategies for Difficult Situations. Ann Surg Oncol. 2019 May; 26(5):1170-1172. View in: Pubmed

      • A randomized study to improve care for young women with breast cancer at community and academic medical oncology practices in the United States: The Young and Strong study. Cancer. 2019 06 01; 125(11):1799-1806. View in: Pubmed

      • Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230. J Natl Cancer Inst. 2019 02 01; 111(2):210-213. View in: Pubmed

      • Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients. Reprod Biomed Online. 2019 May; 38(5):835-844. View in: Pubmed

      • Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063. View in: Pubmed

      • Case-control study of heart rate abnormalities across the breast cancer survivorship continuum. Cancer Med. 2019 01; 8(1):447-454. View in: Pubmed

      • Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application. Cancer Treat Rev. 2019 Jan; 72:65-77. View in: Pubmed

      • Reply to V. Turan et al. J Clin Oncol. 2019 01 01; 37(1):86-88. View in: Pubmed

      • Pregnancy after cancer: Timing is everything. Cancer. 2018 11 15; 124(22):4290-4291. View in: Pubmed

      • Open-label placebo reduces fatigue in cancer survivors: a randomized trial. Support Care Cancer. 2019 Jun; 27(6):2179-2187. View in: Pubmed

      • Pregnancy-Associated Cancer: A U.S. Population-Based Study. J Womens Health (Larchmt). 2019 02; 28(2):250-257. View in: Pubmed

      • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2018 Oct 01; 29(10):2153. View in: Pubmed

      • The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients. Breast. 2018 Dec; 42:41-49. View in: Pubmed

      • Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause. 2018 06; 25(6):596-608. View in: Pubmed

      • Psychosocial needs of young breast cancer survivors in Mexico City, Mexico. PLoS One. 2018; 13(5):e0197931. View in: Pubmed

      • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2018 08 10; 36(23):2433-2443. View in: Pubmed

      • Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2018 07 01; 36(19):1981-1990. View in: Pubmed

      • Counterpoint: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients. Ovarian Ablation Is a Viable Option for Select Patients. Oncology (Williston Park). 2018 04 15; 32(4):168, 171, 179. View in: Pubmed

      • "I don't want to take chances.": A qualitative exploration of surgical decision making in young breast cancer survivors. Psychooncology. 2018 06; 27(6):1524-1529. View in: Pubmed

      • Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2018 07 01; 36(19):1994-2001. View in: Pubmed

      • The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance). J Geriatr Oncol. 2018 05; 9(3):221-227. View in: Pubmed

      • Anxiety and Depression in Young Women With Metastatic Breast Cancer: A Cross-Sectional Study. Psychosomatics. 2018 May - Jun; 59(3):251-258. View in: Pubmed

      • Exogenous reproductive hormone use in breast cancer survivors and previvors. Nat Rev Clin Oncol. 2018 04; 15(4):249-261. View in: Pubmed

      • Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin. J Clin Oncol. 2018 03 01; 36(7):682-688. View in: Pubmed

      • Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2018 02 20; 36(6):543-553. View in: Pubmed

      • Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. Ann Oncol. 2018 01 01; 29(1):281-282. View in: Pubmed

      • Randomized trial of a clinic-based weight loss intervention in cancer survivors. J Cancer Surviv. 2018 04; 12(2):186-195. View in: Pubmed

      • ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3). Breast. 2017 Oct; 35:203-217. View in: Pubmed

      • Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials. Ann Surg Oncol. 2017 Nov; 24(12):3534-3540. View in: Pubmed

      • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol. 2017 08 01; 28(8):1700-1712. View in: Pubmed

      • Risk communication and decision-making in the prevention of invasive breast cancer. Breast. 2017 Aug; 34 Suppl 1:S55-S57. View in: Pubmed

      • Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer. J Adolesc Young Adult Oncol. 2017 Sep; 6(3):429-434. View in: Pubmed

      • Ovarian Suppression for Women Younger Than 35 Years: New Data to Support Informed Decision Making. J Clin Oncol. 2017 09 20; 35(27):3092-3094. View in: Pubmed

      • Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy? Breast Cancer Res Treat. 2017 Oct; 165(3):545-553. View in: Pubmed

      • Emerging Data and Current Challenges for Young, Old, Obese, or Male Patients with Breast Cancer. Clin Cancer Res. 2017 Jun 01; 23(11):2647-2654. View in: Pubmed

      • Unmet Needs in Clinical Research in Breast Cancer: Where Do We Need to Go? Clin Cancer Res. 2017 Jun 01; 23(11):2611-2616. View in: Pubmed

      • A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative. JAMA Oncol. 2017 May 01; 3(5):677-685. View in: Pubmed

      • Oncofertility: Fertile Ground for Conflict Between Patient Autonomy and Medical Values. Oncologist. 2017 07; 22(7):860-863. View in: Pubmed

      • Survival benefit needed to undergo chemotherapy: Patient and physician preferences. Cancer. 2017 Aug 01; 123(15):2821-2828. View in: Pubmed

      • Fertility concerns among breast cancer patients in Mexico. Breast. 2017 Jun; 33:71-75. View in: Pubmed

      • Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review. JAMA Oncol. 2017 Mar 01; 3(3):402-409. View in: Pubmed

      • Research needs in breast cancer. Ann Oncol. 2017 02 01; 28(2):208-217. View in: Pubmed

      • Reply to L. Del Mastro and A. Prat. J Clin Oncol. 2017 04 01; 35(10):1139. View in: Pubmed

      • Looking back, moving forward: the evolution of cancer survivorship care. Lancet Oncol. 2017 01; 18(1):18-19. View in: Pubmed

      • Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527. J Clin Oncol. 2017 Feb; 35(4):421-431. View in: Pubmed

      • Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers. Cancer Discov. 2017 02; 7(2):202-217. View in: Pubmed

      • The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov. 2017 02; 7(2):177-187. View in: Pubmed

      • Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors. Cancer. 2017 Apr 01; 123(7):1249-1258. View in: Pubmed

      • Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 01; 161(2):363-373. View in: Pubmed

      • Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Breast Cancer Res Treat. 2016 12; 160(3):393-410. View in: Pubmed

      • Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv. 2017 02; 11(1):74-79. View in: Pubmed

      • Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. J Clin Oncol. 2016 09 20; 34(27):3308-14. View in: Pubmed

      • Randomized phase 2 trial of a coordinated breast cancer follow-up care program. Cancer. 2016 Nov 15; 122(22):3546-3554. View in: Pubmed

      • Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Res Treat. 2016 08; 159(1):109-18. View in: Pubmed

      • Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer. Breast Cancer Res Treat. 2016 07; 158(2):243-51. View in: Pubmed

      • A pilot videoconference group stress management program in cancer survivors: lessons learned. Rural Remote Health. 2016 Apr-Jun; 16(2):3863. View in: Pubmed

      • BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer. JAMA Oncol. 2016 Jun 01; 2(6):730-6. View in: Pubmed

      • Evaluating the Utility of Baseline Cardiac Function Screening in Early-Stage Breast Cancer Treatment. Oncologist. 2016 06; 21(6):666-70. View in: Pubmed

      • Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline. J Clin Oncol. 2016 07 10; 34(20):2416-27. View in: Pubmed

      • Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety. J Natl Compr Canc Netw. 2016 03; 14(3):355-63. View in: Pubmed

      • A pilot trial of brief group cognitive-behavioral treatment for insomnia in an adult cancer survivorship program. Psychooncology. 2017 06; 26(6):843-848. View in: Pubmed

      • Randomized trial of a physical activity intervention in women with metastatic breast cancer. Cancer. 2016 Apr 15; 122(8):1169-77. View in: Pubmed

      • Second international consensus guidelines for breast cancer in young women (BCY2). Breast. 2016 Apr; 26:87-99. View in: Pubmed

      • Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016 Jan 04; 14:1. View in: Pubmed

      • Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics. J Clin Oncol. 2016 Feb 20; 34(6):539-41. View in: Pubmed

      • Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer. J Adolesc Young Adult Oncol. 2016 Mar; 5(1):16-23. View in: Pubmed

      • Prevention of Premature Menopause and Preservation of Fertility in Young Cancer Survivors: Hopeful Though Modest Long-term Results. JAMA. 2015 Dec 22-29; 314(24):2625-7. View in: Pubmed

      • Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics. Patient Prefer Adherence. 2015; 9:1587-92. View in: Pubmed

      • Management of breast cancer in very young women. Breast. 2015 Nov; 24 Suppl 2:S154-8. View in: Pubmed

      • Chemotherapy in Premenopausal Breast Cancer Patients. Breast Care (Basel). 2015 Oct; 10(5):307-10. View in: Pubmed

      • Age, race, BMI, and pathologic complete response following neoadjuvant chemotherapy: An analysis of four alliance clinical trials. J Clin Oncol. 2015 Oct; 33(28_suppl):33. View in: Pubmed

      • Breast Cancer in Young Women: Rare Disease or Public Health Problem? JAMA Oncol. 2015 Oct; 1(7):877-8. View in: Pubmed

      • Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015 Dec; 26(12):2408-19. View in: Pubmed

      • A qualitative exploration of supports and unmet needs of diverse young women with breast cancer. J Community Support Oncol. 2015 Sep; 13(9):323-9. View in: Pubmed

      • Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey. Clin Breast Cancer. 2016 Apr; 16(2):105-12. View in: Pubmed

      • New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer. J Natl Cancer Inst. 2015 Oct; 107(10). View in: Pubmed

      • Breast Cancer Management Updates: Young and Older, Pregnant, or Male. Ann Surg Oncol. 2015 Oct; 22(10):3219-24. View in: Pubmed

      • More Options for Premenopausal Women With Early-Stage Hormone-Sensitive Breast Cancer. Oncology (Williston Park). 2015 Jul; 29(7):482, 492. View in: Pubmed

      • Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer. JAMA Oncol. 2015 Jun; 1(3):369-74. View in: Pubmed

      • Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. Oncologist. 2015 Jul; 20(7):713-8. View in: Pubmed

      • Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial). Breast Cancer Res Treat. 2015 Jun; 151(3):589-96. View in: Pubmed

      • Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors. J Clin Oncol. 2015 Jul 10; 33(20):2254-61. View in: Pubmed

      • Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer. Ann Surg Oncol. 2015 Nov; 22(12):3809-15. View in: Pubmed

      • Symptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer. Oncologist. 2015 Jun; 20(6):598-604. View in: Pubmed

      • Partner support and anxiety in young women with breast cancer. Psychooncology. 2015 Dec; 24(12):1679-85. View in: Pubmed

      • Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015 03 05; 372(10):923-32. View in: Pubmed

      • Reply to C. Twelves et Al. J Clin Oncol. 2015 Apr 10; 33(11):1301. View in: Pubmed

      • Breast Cancer in Young Women: Research Priorities. A Report of the Young Survival Coalition Research Think Tank Meeting. J Adolesc Young Adult Oncol. 2015 Mar; 4(1):34-43. View in: Pubmed

      • Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. J Oncol Pract. 2015 Mar; 11(2):e222-9. View in: Pubmed

      • Pregnancy after breast cancer: Are young patients willing to participate in clinical studies? Breast. 2015 Jun; 24(3):201-7. View in: Pubmed

      • Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy. Curr Opin Obstet Gynecol. 2015 Feb; 27(1):98-107. View in: Pubmed

      • Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer. BMC Public Health. 2015 Jan 31; 15:37. View in: Pubmed

      • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 2015 Jan 08; 372(2):134-41. View in: Pubmed

      • Challenges to Standardizing the Care for Adult Cancer Survivors: Highlighting ASCO's Fatigue and Anxiety and Depression Guidelines. Am Soc Clin Oncol Educ Book. 2015; 188-94. View in: Pubmed

      • Chemo- and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract. 2015 Jan; 11(1):42-3. View in: Pubmed

      • Shared Medical Appointments in Cancer Survivorship Care: A Review of the Literature. J Oncol Pract. 2015 01; 11(1):6-11. View in: Pubmed

      • ABCDE steps to prevent heart disease in breast cancer survivors. Circulation. 2014 Oct 28; 130(18):e157-9. View in: Pubmed

      • Informational needs and the quality of life of patients in their first year after metastatic breast cancer diagnosis. J Community Support Oncol. 2014 Oct; 12(10):347-54. View in: Pubmed

      • Developing a service model that integrates palliative care throughout cancer care: the time is now. J Clin Oncol. 2014 Oct 10; 32(29):3330-6. View in: Pubmed

      • Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014 Oct 10; 32(29):3307-29. View in: Pubmed

      • Biology of breast cancer in young women. Breast Cancer Res. 2014 Aug 27; 16(4):427. View in: Pubmed

      • The relationship between the belief in a genetic cause for breast cancer and bilateral mastectomy. Health Psychol. 2015 May; 34(5):473-6. View in: Pubmed

      • The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer. 2014 Jul 12; 14:513. View in: Pubmed

      • Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance). J Clin Oncol. 2014 Jun 20; 32(18_suppl):LBA505. View in: Pubmed

      • Estimates of young breast cancer survivors at risk for infertility in the U.S. Oncologist. 2014 Aug; 19(8):814-22. View in: Pubmed

      • Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen. Clin Breast Cancer. 2014 Dec; 14(6):413-6. View in: Pubmed

      • Contralateral Prophylactic Mastectomy: An Opportunity for Shared Decision Making. JAMA Surg. 2014 Jun; 149(6):589-90. View in: Pubmed

      • Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer. 2014 Aug 01; 120(15):2264-71. View in: Pubmed

      • Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry. Breast Cancer Res Treat. 2014 Jun; 145(2):525-34. View in: Pubmed

      • First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014 Jun; 23(3):209-20. View in: Pubmed

      • Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014 Aug; 21(8):2506-11. View in: Pubmed

      • Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014 May 20; 32(15):1605-19. View in: Pubmed

      • Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Breast Cancer Res Treat. 2014 Apr; 144(3):591-7. View in: Pubmed

      • Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol. 2014 Apr 10; 32(11):1151-6. View in: Pubmed

      • Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014 Jan 20; 32(3):199-205. View in: Pubmed

      • Reply to D. Serraino et al. J Clin Oncol. 2014 Jan 10; 32(2):161. View in: Pubmed

      • Young Women with Breast Cancer: A Focus Group Study of Unmet Needs. J Adolesc Young Adult Oncol. 2013 Dec 01; 2(4):153-160. View in: Pubmed

      • Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013 Dec; 40(6):804-12. View in: Pubmed

      • Breast cancer presentation and diagnostic delays in young women. Cancer. 2014 Jan 01; 120(1):20-5. View in: Pubmed

      • Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40? Breast Cancer Res Treat. 2013 Nov; 142(1):165-75. View in: Pubmed

      • Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice. Breast Cancer Res Treat. 2013 Oct; 141(3):421-7. View in: Pubmed

      • Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013 Sep 17; 159(6):373-81. View in: Pubmed

      • Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013 Oct; 22(5):606-15. View in: Pubmed

      • Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013 Oct; 22(5):593-605. View in: Pubmed

      • Management of breast cancer in very young women. Breast. 2013 Aug; 22 Suppl 2:S176-9. View in: Pubmed

      • Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research. Breast Cancer Res Treat. 2013 Aug; 140(3):447-52. View in: Pubmed

      • Contemporary multidisciplinary treatment of pregnancy-associated breast cancer. Springerplus. 2013 Dec; 2(1):297. View in: Pubmed

      • Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol. 2013 Jul 20; 31(21):2692-8. View in: Pubmed

      • Premature menopause in young breast cancer: effects on quality of life and treatment interventions. J Thorac Dis. 2013 Jun; 5 Suppl 1:S55-61. View in: Pubmed

      • Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jul 01; 31(19):2500-10. View in: Pubmed

      • Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Ann Oncol. 2013 Sep; 24(9):2224-35. View in: Pubmed

      • Predictors of recovery of ovarian function during aromatase inhibitor therapy. Ann Oncol. 2013 Aug; 24(8):2011-6. View in: Pubmed

      • Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist. 2013; 18(4):362-8. View in: Pubmed

      • High performance teamwork training and systems redesign in outpatient oncology. BMJ Qual Saf. 2013 May; 22(5):405-13. View in: Pubmed

      • Quality of life and symptoms in male breast cancer survivors. Breast. 2013 Apr; 22(2):197-199. View in: Pubmed

      • Cancer survivorship and the young breast cancer patient: addressing the important issues. Oncologist. 2013; 18(8):e19-20. View in: Pubmed

      • Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology. J Clin Oncol. 2013 Jan 01; 31(1):131-61. View in: Pubmed

      • Implementation of team training in outpatient breast oncology. J Clin Oncol. 2012 Dec; 30(34_suppl):83. View in: Pubmed

      • Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program. Cancer. 2013 Jan 01; 119(1):158-63. View in: Pubmed

      • Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program. Cancer. 2013 Jan 01; 119(1):164-72. View in: Pubmed

      • Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. Breast Cancer Res Treat. 2012 Dec; 136(3):919-26. View in: Pubmed

      • Body image in recently diagnosed young women with early breast cancer. Psychooncology. 2013 Aug; 22(8):1849-55. View in: Pubmed

      • Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 2012 Dec; 136(3):813-21. View in: Pubmed

      • Fertility (male and female) and menopause. J Clin Oncol. 2012 Oct 20; 30(30):3705-11. View in: Pubmed

      • Receipt of locoregional therapy among young women with breast cancer. Breast Cancer Res Treat. 2012 Oct; 135(3):893-906. View in: Pubmed

      • Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ. J Sex Med. 2013 Feb; 10(2):370-7. View in: Pubmed

      • Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907). Ann Oncol. 2012 Dec; 23(12):3075-3081. View in: Pubmed

      • Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decis Mak. 2012 Jun 08; 12:51. View in: Pubmed

      • Model program to improve care for a unique cancer population: young women with breast cancer. J Oncol Pract. 2012 Sep; 8(5):e105-10. View in: Pubmed

      • The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 2012; 17(6):775-82. View in: Pubmed

      • Challenges in ductal carcinoma in situ risk communication and decision-making: report from an American Cancer Society and National Cancer Institute workshop. CA Cancer J Clin. 2012 May-Jun; 62(3):203-10. View in: Pubmed

      • Quality of life in long-term survivors of metastatic breast cancer. Clin Breast Cancer. 2012 Apr; 12(2):119-26. View in: Pubmed

      • Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates. Cancer. 2012 Oct 01; 118(19):4801-5. View in: Pubmed

      • Coping and psychological distress in young adults with advanced cancer. J Support Oncol. 2012 May-Jun; 10(3):124-30. View in: Pubmed

      • Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy? J Clin Oncol. 2012 Feb 10; 30(5):479-81. View in: Pubmed

      • Clinical problem-solving. Breathless. N Engl J Med. 2012 Jan 05; 366(1):75-81. View in: Pubmed

      • The unique reproductive concerns of young women with breast cancer. Adv Exp Med Biol. 2012; 732:77-87. View in: Pubmed

      • Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Fertil Steril. 2012 Jan; 97(1):154-9. View in: Pubmed

      • Interactive medical case. Breathless. N Engl J Med. 2011 Dec 22; 365(25):e47. View in: Pubmed

      • Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol. 2012 Jan 10; 30(2):158-63. View in: Pubmed

      • Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012 Feb; 131(3):1061-6. View in: Pubmed

      • Decision making about surgery for early-stage breast cancer. J Am Coll Surg. 2012 Jan; 214(1):1-10. View in: Pubmed

      • Commentary: should cost and comparative value of treatments be considered in clinical practice guidelines? J Oncol Pract. 2011 Nov; 7(6):398-401. View in: Pubmed

      • Adjuvant therapies for very young women with early stage breast cancer. Breast. 2011 Oct; 20 Suppl 3:S146-9. View in: Pubmed

      • Reproductive endocrinology: triptorelin ovarian suppression during breast cancer chemotherapy. Nat Rev Endocrinol. 2011 Sep 20; 7(11):637-8. View in: Pubmed

      • American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer. J Clin Oncol. 2011 Oct 10; 29(29):3939-42. View in: Pubmed

      • Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res Treat. 2011 Sep; 129(2):309-17. View in: Pubmed

      • A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases. Clin Breast Cancer. 2011 Dec; 11(6):376-83. View in: Pubmed

      • Patient perspectives on a treatment plan and summary program in community oncology care. J Clin Oncol. 2011 May 20; 29(15_suppl):6027. View in: Pubmed

      • Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103. J Clin Oncol. 2011 May 20; 29(15_suppl):1000. View in: Pubmed

      • Understanding the psychosocial needs of young adults with cancer: Identifying targets for clinical intervention. J Clin Oncol. 2011 May 20; 29(15_suppl):9068. View in: Pubmed

      • Fertility concerns in young women with breast cancer: Results from a prospective cohort study. J Clin Oncol. 2011 May 20; 29(15_suppl):6025. View in: Pubmed

      • The ASCO Breast Cancer Registry pilot: Implementation of a multisite community practice registry and treatment plan/summary program. J Clin Oncol. 2011 May 20; 29(15_suppl):6101. View in: Pubmed

      • A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. J Clin Oncol. 2011 May 20; 29(15_suppl):559. View in: Pubmed

      • Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907. J Clin Oncol. 2011 Mar 10; 29(8):1022-8. View in: Pubmed

      • Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article]. Plast Reconstr Surg. 2011 Jan; 127(1):18-26. View in: Pubmed

      • Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause. 2011 Jan; 18(1):105-8. View in: Pubmed

      • Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. Menopause. 2010 Sep-Oct; 17(5):908-16. View in: Pubmed

      • Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer. J Womens Health (Larchmt). 2010 Aug; 19(8):1553-9. View in: Pubmed

      • Non-adherence: a new epidemic? Eur J Cancer. 2010 Jul; 46(10):1767. View in: Pubmed

      • Medication errors involving oral chemotherapy. Cancer. 2010 May 15; 116(10):2455-64. View in: Pubmed

      • Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol. 2010 May 20; 28(15):2635-40. View in: Pubmed

      • Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol. 2010 May 10; 28(14):2418-22. View in: Pubmed

      • The role of socioeconomic status in adjustment after ductal carcinoma in situ. Cancer. 2010 Mar 01; 116(5):1218-25. View in: Pubmed

      • The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer. 2010 Feb 15; 116(4):791-8. View in: Pubmed

      • On mammography--more agreement than disagreement. N Engl J Med. 2009 Dec 24; 361(26):2499-501. View in: Pubmed

      • Genetic testing in young women with breast cancer: results from a Web-based survey. Ann Oncol. 2010 Apr; 21(4):741-747. View in: Pubmed

      • Doctor-patient communication about advance directives in metastatic breast cancer. J Palliat Med. 2009 Jun; 12(6):547-53. View in: Pubmed

      • Personalizing treatment in early-stage breast cancer: The role of standard clinical factors and genomic information in adjuvant chemotherapy decision making. J Clin Oncol. 2009 May 20; 27(15_suppl):572. View in: Pubmed

      • Presentation of breast cancer in young women. J Clin Oncol. 2009 May 20; 27(15_suppl):6608. View in: Pubmed

      • Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009 May 14; 360(20):2055-65. View in: Pubmed

      • Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril. 2010 Jul; 94(2):638-44. View in: Pubmed

      • Breast cancer in young women: clinical decision-making in the face of uncertainty. Oncology (Williston Park). 2009 May; 23(6):474, 477. View in: Pubmed

      • Is there a role for decision aids in advanced breast cancer? Med Decis Making. 2009 Jul-Aug; 29(4):475-82. View in: Pubmed

      • Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Res Treat. 2009 Oct; 117(3):615-23. View in: Pubmed

      • Adherence with adjuvant hormonal therapy for breast cancer. Ann Oncol. 2009 Mar; 20(3):401-2. View in: Pubmed

      • Sharing study results with trial participants: time for action. J Clin Oncol. 2009 Feb 20; 27(6):838-9. View in: Pubmed

      • Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009 Jan-Feb; 59(1):56-66. View in: Pubmed

      • Optimizing endocrine therapy in premenopausal ER-positive breast cancer patients. Oncology (Williston Park). 2009 Jan; 23(1):34, 40. View in: Pubmed

      • Fertility. Cancer Treat Res. 2009; 151:367-85. View in: Pubmed

      • Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ. Ann Surg Oncol. 2009 Jan; 16(1):106-12. View in: Pubmed

      • Breast cancer in young women: a new color or a different shade of pink? J Clin Oncol. 2008 Jul 10; 26(20):3303-5. View in: Pubmed

      • The impact of sharing results of a randomized breast cancer clinical trial with study participants. Breast Cancer Res Treat. 2009 May; 115(1):123-9. View in: Pubmed

      • Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol. 2008 Oct; 19(10):1669-80. View in: Pubmed

      • Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ. Clin Breast Cancer. 2008 Jun; 8(3):275-80. View in: Pubmed

      • Fertility preservation: a vital survivorship issue for young women with breast cancer. J Clin Oncol. 2008 Jun 01; 26(16):2612-3. View in: Pubmed

      • CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907. J Clin Oncol. 2008 May 20; 26(15_suppl):6542. View in: Pubmed

      • Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):9571. View in: Pubmed

      • Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907. J Clin Oncol. 2008 May 20; 26(15_suppl):507. View in: Pubmed

      • Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol. 2008 Feb 20; 26(6):907-12. View in: Pubmed

      • Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008 Feb 20; 100(4):243-51. View in: Pubmed

      • Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer. 2008 Feb; 8(1):65-9. View in: Pubmed

      • Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008 Feb 01; 26(4):556-62. View in: Pubmed

      • Care of the Cancer Survivor. Lyman, Supportive Care in Oncology, In Press. 2008. View in: Pubmed

      • Reproductive Issues in Breast Cancer Survivors. Diseases of the Breast, In Press. 2008. View in: Pubmed

      • Fertility Preservation Considerations in Young Women with Breast Cancer. American Society Of Clinical Oncology Annual Meeting 2008 Educational Book. 2008. View in: Pubmed

      • Breast Cancer in Young Women. Diseases of the Breast, In Press. 2008. View in: Pubmed

      • Fertility and Adjuvant Treatment in Young Women with Breast Cancer. In Press. 2008. View in: Pubmed

      • Fertility Preservation- A Vital Survivorship Issue for Young Women with Breast Cancer. J Clin Oncol, In Press. 2008. View in: Pubmed

      • Risk Perceptions and Psychosocial Outcomes of Women with Ductal Carcinoma-in-situ (DCIS): Longitudinal Results from a Cohort Study. J Clin Oncol. 2008; 26(6):907-12. View in: Pubmed

      • Fertility. Castiglione M, ed. Adjuvant Therapy for Breast Cancer. 2008. View in: Pubmed

      • Perceptions and Management Approaches of Physicians Who Care for Women with Ductal Carcinoma-in-situ (DCIS). J Natl Cancer Inst. 2008; 100(4):243-51. View in: Pubmed

      • Fertility and adjuvant treatment in young women with breast cancer. Breast. 2007 Dec; 16 Suppl 2:S175-81. View in: Pubmed

      • Challenges in the end-of-life care: Commnication about advance directives between patients and providers. Proceedings from ASCO the 2007 Breast Cancer Symposium. 2007; (abstr 269). View in: Pubmed

      • Exercise behaviors in a group of women with newly diagnosed ductal carcinoma in situ (DCIS). Proceedings from ASCO the 2007 Breast Cancer Symposium. 2007; (abstr 123). View in: Pubmed

      • Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin. 2007 Sep-Oct; 57(5):260-77. View in: Pubmed

      • Genetic testing in young women with breast cancer: Results from a web-based survey. Proc Am Soc Clin Onc. 2007; (abstr 21093). View in: Pubmed

      • Impact of physical activity on insulin levels in breast cancer survivors. Proc Am Soc Clin Oncol. 2007; (abstr 555). View in: Pubmed

      • Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer. 2007 Jul; 43(11):1646-53. View in: Pubmed

      • Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer. 2007 Apr 01; 109(7):1239-46. View in: Pubmed

      • Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007 Feb 24; 334(7590):407. View in: Pubmed

      • Adherence with adjuvant hormonal therapy in breast cancer: a report from the Compliance Strategic Intiative Conference. Community Oncology. 2007; 4:1-7. View in: Pubmed

      • Oral Chemotherapy safety practices at US cancer centres: questionaire survey. BJM. 2007. View in: Pubmed

      • The impact of an exercise invention on body composition, fat distriution, and weight in breast cancer survivors. J Clin Onc. 2007. View in: Pubmed

      • Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. Proc Am Soc Clin Oncol. 2006; (abstr 10560). View in: Pubmed

      • Lymphopenia in dose-dense chemotherapy for early stage breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 2093). View in: Pubmed

      • The effect of paclitaxel, dose density and trastuzumab on chemotherapy-related amenorrhea (CRA) in premenopausal women with breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 2079). View in: Pubmed

      • Adherence with adjuvant anastrozole therapy among women with early stage breast cancer. Breast Cancer Research and Treatment. 2006; (abstr 4044). View in: Pubmed

      • The impact of an exercise intervention on body composition, fat distribution, and weight in breast cancer survivors. Proc Am Soc Clin Onc. 2006; (abstr 590). View in: Pubmed

      • Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer. J Clin Oncol. 2006 Nov 20; 24(33):5330-1. View in: Pubmed

      • An approach to measuring the quality of breast cancer decisions. Patient Educ Couns. 2007 Feb; 65(2):261-9. View in: Pubmed

      • Menopausal-type symptoms in young breast cancer survivors. Ann Oncol. 2006 Dec; 17(12):1777-82. View in: Pubmed

      • Study participants' perceptions of the process and impact of receiving results of N9831. J Clin Oncol. 2006 Jun 20; 24(18_suppl):518. View in: Pubmed

      • Combination therapy with gefitinib and capecitabine in metastatic breast cancer (MBC): A phase I trial. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10564. View in: Pubmed

      • Chemotherapy-related amenorrhea in women with early breast cancer: The effect of paclitaxel or dose density. J Clin Oncol. 2006 Jun 20; 24(18_suppl):10506. View in: Pubmed

      • Combination therapy with gefitnib and capecitabine in metastatic breast cancer (MBC): A phase I trial. Proc Am Soc Clin Oncol. 2006; (abstr 10564). View in: Pubmed

      • Study Participants' perceptions of the process and impact of receiving results N9831. Proc Am Soc Clin Onc. 2006; (abstr 518). View in: Pubmed

      • American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006 Jun 20; 24(18):2917-31. View in: Pubmed

      • Non-adherence to endocrine therapy for breast cancer. Ann Oncol. 2006 Feb; 17(2):183-4. View in: Pubmed

      • Non-adherence to endocrine therapy for breast cancer. Annals of Oncology. 2006; 17:183-84. View in: Pubmed

      • American Society of Clinical Oncology Recommendations on Fertility Preservation in People Treated for Cancer. J Clin Onc. 2006; 24:2917-31. View in: Pubmed

      • Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons. Clin Breast Ca. 2006; 7:158-61. View in: Pubmed

      • Contributing author in: Berg WA, Birdwell RL eds. Diagnostic Imaging: Breast. 2006. View in: Pubmed

      • Overestimation of risk among women with DCIS: longitudinal results from a cohort study. Breast Cancer Research and Treatment. 2005; (abst 6072). View in: Pubmed

      • Standards for follow-up care of patents with breast cancer. Breast. 2005 Dec; 14(6):500-8. View in: Pubmed

      • Attitudes and management approaches of physicians who care for women with DCIS. Breast Cancer Research and Treatment. 2005; abst 6068. View in: Pubmed

      • Premature menopause following chemotherapy for early stage breast cancer: long term results from IBCSG trials V and VI. Breast Cancer Research and Treatment. 2005; (abstr 6055). View in: Pubmed

      • Metronomic chemotherapy with and without bevacizumab for advanced breast cancer: a randomized phase II study. Breast Cancer Research and Treatment. 2005; (abst 4). View in: Pubmed

      • Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol. 2005 Nov 20; 23(33):8340-7. View in: Pubmed

      • Young women's preferences about adjuvant endocrine therapy for breast cancer. Lancet Oncol. 2005 Aug; 6(8):542-4. View in: Pubmed

      • Preserving fertility after cancer. CA Cancer J Clin. 2005 Jul-Aug; 55(4):211-28; quiz 263-4. View in: Pubmed

      • Delayed premature menopause following chemotherapy for early stage breast cancer: Long-term results from IBCSG Trial V. J Clin Oncol. 2005 Jun; 23(16_suppl):687. View in: Pubmed

      • Pharmaceutical involvement in breast cancer clinical trials. J Clin Oncol. 2005 Jun; 23(16_suppl):6057. View in: Pubmed

      • Measuring Decision Quality: Lessons from Pilot Testing. 3rd International Shared Decision Making Conference. 2005. View in: Pubmed

      • Shared Decision Making and Posttraumatic Growth in Early-Stage Breast Cancer Survivors. 3rd International Shared Decision Making Conference. 2005. View in: Pubmed

      • Delayed premature menopause following chemotherapy for early stage breast cancer: long-term results from IBCSG Trial V. Proc Am Soc Clin Oncol. 2005. View in: Pubmed

      • Pregnancy and breast cancer: epidemiology, treatment, and safety issues. Oncology (Williston Park). 2005 May; 19(6):693-7; discussion 697-700. View in: Pubmed

      • Fertility after breast cancer: questions abound. J Clin Oncol. 2005 Jul 01; 23(19):4259-61. View in: Pubmed

      • Offering participants results of a clinical trial: sharing results of a negative study. Lancet. 2005 Mar 12-18; 365(9463):963-4. View in: Pubmed

      • Ethical and clinical dilemmas resulting from the early closure of recent clinical trials in breast cancer. American Society of Clinical Oncology Annual Meeting, 2005 Educational Book. 2005; 230-41. View in: Pubmed

      • Breast Cancer in Young Women. American Society of Clinical Oncology Annual Meeting 2005 Educational Book. 2005; 61-7. View in: Pubmed

      • Concerns about fertility after breast cancer in young women. Am J Oncol Rev. 2005; 4:1-3. View in: Pubmed

      • Use of the Long-acting Hematopoietic Growth Factors Pegfilgrastim and Darbepoetin in Support of Dose-Dense Adjuvant Chemotherapy. Breast Cancer Research and Treatment. 2004. View in: Pubmed

      • Menopausal Symptoms in Very Young Breast Cancer Survivors. Breast Cancer Research and Treatment. 2004. View in: Pubmed

      • Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004 Oct 15; 22(20):4174-83. View in: Pubmed

      • Fertility outcomes in young women with breast cancer: A Web-based survey. J Clin Oncol. 2004 Jul 15; 22(14_suppl):6085. View in: Pubmed

      • Fertility Outcomes in Young Women with Breast Cancer: A Web-based Survey. Proc Am Soc Clin Oncol. 2004. View in: Pubmed

      • Women with Ductal Carcinoma-in-situ Have Inaccurate Risk Perception. Proc Am Soc Clin Oncol. 2004. View in: Pubmed

      • Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants. J Natl Cancer Inst. 2004 Apr 21; 96(8):629-32. View in: Pubmed

      • Long-term complications of adjuvant chemotherapy for early stage breast cancer. Breast Dis. 2004; 21:55-64. View in: Pubmed

      • Follow-up care of breast cancer survivors. Semin Oncol. 2003 Dec; 30(6):817-25. View in: Pubmed

      • Breast cancer risk communication: challenges and future research directions: workshop report (United States). Cancer Causes Control. 2003 Apr; 14(3):235-9. View in: Pubmed

      • Do patients participating in clinical trials want to know study results? J Natl Cancer Inst. 2003 Mar 19; 95(6):491-2. View in: Pubmed

      • Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003 Feb 15; 21(4):602-6. View in: Pubmed

      • Breast cancer risk communication: Challenges abd future directions. Cancer Causes and Control. 2003; 14:235-29. View in: Pubmed

      • Geriatric Medicine: An Evidence-Based Approach 4th ed. New York: Springer-Verlag. 2003; 393-416. View in: Pubmed

      • Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus. 2003; 12(4):280-6. View in: Pubmed

      • Informing clinical trial participants about study results. JAMA. 2002 Jul 17; 288(3):363-5. View in: Pubmed

      • Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 May 01; 94(9):652-61. View in: Pubmed

      • Treatment of breast cancer during pregnancy. Expert Opin Pharmacother. 2002 Apr; 3(4):423-8. View in: Pubmed

      • Review of: One Story Two Voices. J Palliative Med. 2002; 5:438-9. View in: Pubmed

      • New instruments to measure decision quality for breast cancer. Accepted for the Society for Medical Decision Making 27th Annual Meeting. 2002. View in: Pubmed

      • A phase I study of oral cyclophosphamide and UFT + leucovorin (Orzel) in women with advanced breast cancer. Proc Am Soc Clin Oncol. 2001. View in: Pubmed

      • Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2001 May 15; 19(10):2722-30. View in: Pubmed

      • Quality of life issues among women undergoing high-dose chemotherapy for breast cancer. Breast Dis. 2001; 14:41-50. View in: Pubmed

      • Side effects of chemotherapy and combined chemohormonal therapy in women with early stage breast cancer. J Natl Cancer Institute. 2001; 30:135-42. View in: Pubmed

      • Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer. J Natl Cancer Inst Monogr. 2001; (30):135-42. View in: Pubmed

      • Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol. 2000 Dec; 27(6):712-26. View in: Pubmed

      • Nonmalignant diagnoses in patients. Case 1. Mediastinal lymphadenopathy associated with congestive heart failure. J Clin Oncol. 2000 Jul; 18(13):2635-6. View in: Pubmed

      • Use of taxanes in the treatment of patients with breast cancer has increased dramatically over the past 8 years. Clin Breast Cancer. 2000 Jul; 1(2):164-5. View in: Pubmed

      • Nonmalignant diagnoses in patients. Case 2. Lung cancer with mediastinal lymphadenopathy due to amyloidosis. J Clin Oncol. 2000 Jul; 18(13):2636-7. View in: Pubmed

      • Letter to the Editor on "Taxanes and Breast Cancer: An Evidence-Based Review of Randomized Phase II and Phase III Trials.". Clin Breast Cancer. 2000; 1:165-65. View in: Pubmed

      • Treatment of primary resistant or relapsed multiple myeloma with high-dose chemoradiotherapy, hematopoietic stem cell rescue, and granulocyte-macrophage colony-stimulating factor. Biol Blood Marrow Transplant. 2000; 6(4A):448-55. View in: Pubmed

      • The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol. 1999 Jul; 104(1):123-7. View in: Pubmed

      • Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum. 1997 Dec; 40(12):2199-206. View in: Pubmed

      • Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation. Arthritis Rheum. 1997 Jan; 40(1):57-61. View in: Pubmed

      • The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum. 1995 Feb; 38(2):267-73. View in: Pubmed

      • Evaluation of Social Security disability in claimants with rheumatic disease. Ann Intern Med. 1991 Jul 01; 115(1):26-31. View in: Pubmed

      • Rehabilitation management of homebound elderly with locomotor disability. Clin Geriatr Med. 1988 May; 4(2):431-9. View in: Pubmed

      • Evaluation of a rehabilitation component of home care for homebound elderly. Am J Prev Med. 1986 Jan-Feb; 2(1):30-4. View in: Pubmed

      Locations

      Location Avtar

      Dana-Farber Cancer Institute

      450 Brookline Avenue Boston, MA 02215
      Get Directions

      Dana-Farber Cancer Institute

      Location Avtar

      Dana-Farber Cancer Institute

      450 Brookline Avenue Boston, MA 02215
      Get Direction
      42.3374, -71.1083

      Ratings and Comments

      Ann H. Partridge, MD, MPH

      About Our Ratings

      Physician Star Rating Comment Block

      Discovery and Insights

      Back to Top